Intradermal Influenza Vaccine Elicits Superior Immunogenicity in Adults Aged ≥60 Years: A Randomized Controlled Phase 3 Trial  by Arnou, R. et al.
(Ora
6
w
c
i
p
d
7
C
N
A
S
f
t
t
b
w
s
m
m
b
m
w
D
b
w
s
f
f
i
p
1
p
a
m
i
t
increases the sensitivity of smear negative specimens irre-
spective of the staining method used. However, FM appears
to be more sensitive than ZN.
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28% (1360/4890); 45% (520/1154) in meningitis and 22%
(840/3736) in other IPD cases (p < 0.001). Of patients tested
for HIV, HIV-seroprevalence was 512/664 (77%) amongst
meningitis cases and 2062/2346 (88%) amongst other IPD
(p < 0.001). On multivariable analysis of meningitis cases,
HIV-coinfection was associated with increased odds of death
when controlling for age group, severity of illness [Pitt bac-
teraemia score], prior antibiotic use and province (odds ratio
2.2, 95% conﬁdence interval 1.3—3.6). HIV-coinfection was
not an independent risk factor for death in other IPD cases.
Conclusions: Pneumococcal meningitis has a high mor-
tality in South Africa, and HIV-infected patients are at
increased risk of death. Access to antiretroviral therapy for
HIV-positive patients and introduction of the pneumococ-
cal conjugate vaccine for routine immunization should be
prioritized.
doi:10.1016/j.ijid.2008.05.008
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Background: Annual trivalent inactivated vaccines (TIV)
provide protection against inﬂuenza and its complications
for hundreds of millions of individuals. Yet among adults
aged ≥60 years, vaccine efﬁcacy is lower than in younger
adults. Elderly adults are also the most at risk, with the high-
est inﬂuenza morbidity and mortality. An inﬂuenza vaccine,
injected using a novel intradermal microinjection system,
has been developed with the aim of offering improved pro-
tection for this vulnerable population.
Methods: A multicenter, randomized controlled phase
3 trial was conducted to assess whether TIV given via
ID microinjection induces a superior immune response in
adults ≥60 years, compared with an intramuscular (IM) con-
trol vaccine (Vaxigrip®). Each vaccine dose contained 15g
hemagglutinin/strain. Strain-speciﬁc hemagglutination inhi-
bition titers were assessed on D0 and 21 using a standard
assay.
Results: 3701 subjects aged 60—94 years (mean:
70.8± 6.8) were enrolled and vaccinated ID (n = 2612) or IM
(n = 1089). 54.4% were female. Seroprotection rates were
signiﬁcantly higher in the ID group (p = 0.0003 for H1N1 and
B, p < 0.0001 for H3N2) with a difference of 5.5—6.6 percent-
age for each strain. Mean titer increases after ID vaccination
were: H1N1 3.97, H3N2 8.19 and B 3.61, which were 24.5%,
53.1% and 18.8% higher (p < 0.0001) than the corresponding
values in the IM group. Seroconversion rates among those
with a prevaccination titer <10 were signiﬁcantly higher with
ID: H1N1 64.3% vs 55.6% p = 0.0127, H3N2 80.9% vs 69.3%
p = 0.0003 and B 41.3% vs 35.5% p = 0.0282.l Presentations) e47
Conclusion: In a large phase 3 population of adults aged
0—94, the immunogenicity of a new ID inﬂuenza vaccine
as superior to that of a conventional IM control vac-
ine. Increased serum antibody responses should provide
mproved protection against inﬂuenza for this vulnerable
opulation.
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Background: The reliability of direct smear microscopy
or diagnosis of tuberculosis (TB) using Ziehl-Neelsen (ZN)
echnique has frequently been questioned due to low sensi-
ivity. Fluorescent microscopy (FM) is more sensitive than ZN
ut its sensitivity is less than culture. Treatment of sputum
ith bleach has been used to increase sensitivity in many
ettings. However, no study has compared use FM and ZN
ethods for detection of acid-fast bacilli (AFB) using bleach
ethod.
Objectives: Comparison of results with ﬂuorescence and
right-ﬁeld microscopy for AFB using bleach centrifugation
ethod.
Methods: Three hundred and seventy sputum specimens
ere collected from new TB suspects attending Mbagathi
istrict Hospital and processed for direct microscopy using
oth ZN and FM. Culture on Loweinstein Jensen egg media
as used as the gold standard. FM and ZN smear negative
pecimens were treated with 3.5% bleach and left to stand
or 30minutes before centrifugation. Smears were prepared
rom each bleach treated specimen, processed and exam-
ned using either ZN or FM staining methods.
Results: Of the 370 specimens, 200(54%) were culture
ositive. The number of smear positive by direct ZN was
38 (37.2%) which increased to 171 (46.2%) and direct FM
ositive was 165 (44.6%) which increased to 180 (48.6%),
fter treatment of direct ZN and FM smear negative speci-
ens with 3.5% bleach, respectively. There was a signiﬁcant
ncrease in sensitivity from 66% to 81.1% (p < 0.05) using ZN
echnique and 75.5% to 83% (p < 0.05).
Conclusion: Bleach centrifugation method signiﬁcantly
